IPO registrations (S-1, F-1) · Registrants
Loxo Oncology, Inc.
- SEC CIK
- 1581720 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-06-30, last 2014-07-30; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2014-08-01; declared effective 2014-07-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 281 TRESSER BOULEVARD, 9TH FLOOR, Stamford, CT 06901
- EIN
- 46-2996673
- EDGAR entity type
- operating
- Insiders and CEO pay
- Loxo Oncology, Inc. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2014-07-30)
- Final price
- $13.00 per share, within the range (424B4 filed 2014-08-01, an initial public offering)
- Shares sold
- 5,261,538
- Gross proceeds
- $68,399,994 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol LOXO
- Lead underwriters
- Cowen; Stifel
- Syndicate
- Oppenheimer; JMP Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: LOXO ONCOLOGY, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Loxo Oncology, Inc. Fuzzy (name and state)
- Business registration: LOXO ONCOLOGY, INC. Fuzzy (name and state)
- Form D issuer: Loxo Oncology, Inc. EXACT (CIK (EXACT))
- SEC filer: Loxo Oncology, Inc. EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: Krishna Kittu Kolluri Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-06-30 | S-1 | S-1 (registration) | Loxo Oncology, Inc. | 0001047469-14-005954 ↗ |
| 2014-07-21 | S-1/A | S-1/A (amendment) | Loxo Oncology, Inc. | 0001047469-14-006303 ↗ |
| 2014-07-30 | S-1/A | S-1/A (amendment) | Loxo Oncology, Inc. | 0001047469-14-006498 ↗ |
| 2014-07-31 | S-1MEF | S-1MEF (added securities) | Loxo Oncology, Inc. | 0001104659-14-055596 ↗ |
| 2014-07-31 | EFFECT | EFFECT (declared effective) | Loxo Oncology, Inc. | 9999999995-14-002342 ↗ |
| 2014-08-01 | 424B4 | 424B4 (final prospectus) | Loxo Oncology, Inc. | 0001047469-14-006588 ↗ |
| 2015-08-11 | EFFECT | EFFECT (declared effective) | Loxo Oncology, Inc. | 9999999995-15-002256 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-07-30 | S-1/A | registration statement | $12.00–$14.00 | 4,384,615 | - | Nasdaq LOXO | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2014-08-01 | 424B4 | final prospectus | $13.00 | 5,261,538 | $68,399,994 | Nasdaq LOXO | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ACCESS INDUSTRIES MANAGEMENT, LLC | TenPercentOwner | 2 | 2014 | ||
| AI Loxo Holdings LLC | TenPercentOwner | 2 | 2014 | ||
| AISLING CAPITAL III LP | TenPercentOwner | 10 | 2014–2018 | ||
| Aisling Capital Partners III LLC | TenPercentOwner | 10 | 2014–2018 | ||
| Aisling Capital Partners III LP | TenPercentOwner | 10 | 2014–2018 | ||
| AI Value Holdings, LLC | TenPercentOwner | 2 | 2014 | ||
| BARRETT M JAMES | Director,TenPercentOwner | 4 | 2014–2015 | ||
| BARRIS PETER J | TenPercentOwner | 2 | 2014 | ||
| BASKETT FOREST | TenPercentOwner | 2 | 2014 | ||
| Bilenker Joshua H. | Director,Officer | President & CEO | 26 | 2014–2019 | |
| Blavatnik Len | TenPercentOwner | 2 | 2014 | ||
| Bonita David P | Director; Director,TenPercentOwner | 10 | 2014–2017 | ||
| DEERFIELD MANAGEMENT CO | TenPercentOwnerOther | 3 | 2014 | ||
| Deerfield Mgmt L.P. | TenPercentOwnerOther | 3 | 2014 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 3 | 2014 | ||
| Deerfield Special Situations International Master Fund, L.P. | TenPercentOwnerOther | 3 | 2014 | ||
| DRANT RYAN D | TenPercentOwner | 2 | 2014 | ||
| ELMS STEVE | Director,TenPercentOwner; TenPercentOwner | 18 | 2014–2019 | ||
| Flaherty Keith T. | Director | 17 | 2014–2019 | ||
| Florence Anthony A. Jr. | TenPercentOwner | 2 | 2014 | ||
| Flynn James E | TenPercentOwnerOther | 3 | 2014 | person page Fuzzy | |
| GOLDSTEIN DOV A MD | Director,Officer,TenPercentOwner; Officer,TenPercentOwner | CFO and Treasurer | 6 | 2014–2015 | |
| ISALY SAMUEL D | Director; TenPercentOwner | 6 | 2014–2017 | ||
| KERINS PATRICK J | TenPercentOwner | 2 | 2014 | ||
| KOLLURI KRISHNA KITTU | TenPercentOwner | 2 | 2014 | person page Fuzzy | |
| Low Jennifer A. | Officer | Chief Medical Officer; EVP, Development & Research | 2 | 2014 | |
| MOTT DAVID M | TenPercentOwner | 2 | 2014 | ||
| Moyer Mikel Paul | Officer | Chief Scientific Officer | 1 | 2014 | |
| Naider Avi Z. | Director | 14 | 2014–2019 | ||
| NEA 14 GP, LTD | TenPercentOwner | 2 | 2014 | ||
| NEA Partners 14, L.P. | TenPercentOwner | 2 | 2014 | ||
| New Enterprise Associates 14, L.P. | TenPercentOwner | 2 | 2014 | ||
| ORBIMED ADVISORS LLC | Director; TenPercentOwner | 6 | 2014–2017 | ||
| OrbiMed Capital GP V LLC | Director; TenPercentOwner | 6 | 2014–2017 | ||
| Purcell Dennis J | TenPercentOwner | 10 | 2014–2018 | ||
| SANDELL SCOTT D | TenPercentOwner | 2 | 2014 | ||
| SCHIFF ANDREW N | TenPercentOwner | 10 | 2014–2018 | ||
| Sonsini Peter W. | TenPercentOwner | 2 | 2014 | ||
| Viswanathan Ravi | TenPercentOwner | 2 | 2014 | ||
| Weller Harry R | TenPercentOwner | 2 | 2014 | ||
| ARRAY BIOPHARMA INC | TenPercentOwner | 4 | 2014 | ||
| Deerfield International Master Fund, L.P. | TenPercentOwnerOther | 1 | 2014 | ||
| DEERFIELD PARTNERS, LP | TenPercentOwnerOther | 1 | 2014 | ||
| Kunkel Lori Anne | Director | 11 | 2014–2019 | ||
| Fuhrman Alan | Director | 8 | 2015–2019 | ||
| Burstein Jennifer | Officer | Senior VP of Finance; Vice President of Finance | 25 | 2015–2019 | |
| MAYLEBEN TIMOTHY M | Director | 9 | 2015–2019 | ||
| Van Naarden Jacob | Officer | Chief Business Officer; Chief Operating Officer | 24 | 2016–2019 | |
| Harr Steve | Director | 5 | 2016–2019 | ||
| Nanda Nisha | Officer | Chief Development Officer | 3 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-05-12 | Loxo Oncology, Inc. | Biotechnology | $23,888,747 | $23,888,747 | 7 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Loxo Oncology, Inc. | CT | State business registries | name and state |
| Business registration | LOXO ONCOLOGY, INC. | CT | State business registries | name and state |
| Business registration | LOXO ONCOLOGY, INC. | CT | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | Loxo Oncology, Inc. | CT | Form D private offerings | CIK (EXACT) |
| Patent assignee | Loxo Oncology, Inc. | CT | Patents (USPTO) | name and state |
| SEC filer | Loxo Oncology, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Loxo Oncology, Inc. | CT | Trademarks (USPTO) | name and state |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) | |
| Person page | Krishna Kittu Kolluri | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.